Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation

BACKGROUND: Major concerns about the safety of pretransplant amiodarone use have been raised. As a result of its long half-life, the cardiac allograft is exposed to amiodarone posing potential risks such as bradycardia, requirement for pacemaker implantation, or increased mortality after heart trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivinius, Rasmus, Helmschrott, Matthias, Ruhparwar, Arjang, Darche, Fabrice F, Thomas, Dierk, Bruckner, Tom, Katus, Hugo A, Doesch, Andreas O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484508/
https://www.ncbi.nlm.nih.gov/pubmed/28684901
http://dx.doi.org/10.2147/DDDT.S136948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484508/
https://www.ncbi.nlm.nih.gov/pubmed/28684901
http://dx.doi.org/10.2147/DDDT.S136948

Ejemplares similares